Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 01-2013 | 12-2012 | 01-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,450 | -16,225 | 2,522 | -17,354 | 392 |
| Depreciation Amortization | 1,142 | 867 | 582 | 683 | 577 |
| Income taxes - deferred | N/A | N/A | 920 | N/A | 436 |
| Accounts receivable | N/A | N/A | -414 | N/A | -655 |
| Accounts payable and accrued liabilities | 869 | -617 | -873 | 860 | -116 |
| Other Working Capital | 1,933 | -2,820 | -551 | 2,232 | -1,866 |
| Other Operating Activity | -458 | 1,894 | 8 | 443 | 2,756 |
| Operating Cash Flow | $-13,964 | $-16,901 | $2,194 | $-13,136 | $1,524 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -504 | -898 | 615 | -5,755 | -1,068 |
| Purchase Of Investment | N/A | 0 | N/A | -32,765 | N/A |
| Sale Of Investment | 3,294 | 23,550 | N/A | 22,658 | N/A |
| Purchase Sale Intangibles | -258 | -242 | N/A | -211 | N/A |
| Other Investing Activity | -258 | -313 | 0 | -205 | 0 |
| Investing Cash Flow | $2,532 | $22,339 | $615 | $-16,067 | $-1,068 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -7,051 | -2,209 | 5,356 | 799 |
| Debt Repayment | -34 | -45 | -757 | -47 | -1,260 |
| Common Stock Issued | 12,817 | 249 | N/A | 23,003 | N/A |
| Other Financing Activity | 2 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $12,785 | $-6,847 | $-2,966 | $28,312 | $-461 |
| Beginning Cash Position | 803 | 2,212 | 157 | 3,103 | 162 |
| End Cash Position | 2,156 | 803 | N/A | 2,212 | 157 |
| Net Cash Flow | $1,353 | $-1,409 | $-157 | $-891 | $-5 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,964 | -16,901 | 2,194 | -13,136 | 1,524 |
| Capital Expenditure | -504 | -898 | -780 | -5,755 | -1,068 |
| Free Cash Flow | -14,468 | -17,799 | 1,414 | -18,891 | 456 |